Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Haleon PLC (GB:HLN – Research Report) and Stoke Therapeutics (STOK – Research Report).
Haleon PLC (GB:HLN)
In a report released yesterday, Victoria Petrova from Bank of America Securities reiterated a Buy rating on Haleon PLC, with a price target of p400.00. The company’s shares closed last Wednesday at p322.00.
According to TipRanks.com, Petrova is ranked #8116 out of 8799 analysts.
Haleon PLC has an analyst consensus of Moderate Buy, with a price target consensus of p361.92, which is a 12.1% upside from current levels. In a report issued on March 26, Morgan Stanley also maintained a Buy rating on the stock with a p365.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Stoke Therapeutics (STOK)
In a report issued on April 2, Jessica Fye from J.P. Morgan maintained a Hold rating on Stoke Therapeutics, with a price target of $14.00. The company’s shares closed last Tuesday at $12.85.
According to TipRanks.com, Fye is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Stoke Therapeutics with a $23.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on GB:HLN:
